Stocks Moving Premarket: PPCB, BTAI, TNXP, DAY, TPIC, and Other Gainers & Losers

Propanc Biopharma Inc. (PPCB) is up 252% to $10.13, while TPI Composites Inc. (TPIC) is down 54% to $0.10 in premarket trading. Other notable movers include BioXcel Therapeutics Inc. (BTAI), up 20% to $6.57, and Tonix Pharmaceuticals Holding Corp. (TNXP), up 13% to $58.14.

Propanc Biopharma Inc. (PPCB) and TPI Composites Inc. (TPIC) are experiencing significant movements in premarket trading. Propanc Biopharma Inc. has seen a substantial increase, rising by 252% to $10.13, while TPI Composites Inc. has decreased by 54% to $0.10. Other notable movers include BioXcel Therapeutics Inc. (BTAI), which has gained 20% to $6.57, and Tonix Pharmaceuticals Holding Corp. (TNXP), which has increased by 13% to $58.14.

Propanc Biopharma Inc. has been in the spotlight recently with its public offering and Nasdaq uplisting. The company announced a public offering of 1 million shares at $4.00 each, expecting to raise around $4 million before expenses. The offering is set to close on August 18, 2025, following the company's approval to list its common stock on the Nasdaq Capital Market, with trading anticipated to start on August 15, 2025 [2]. This move is expected to enhance the company's visibility and market access, potentially leading to increased liquidity and investment opportunities.

TPI Composites Inc., on the other hand, has been experiencing volatility. The company initiated voluntary Chapter 11 proceedings to facilitate restructuring and position the company for long-term success. The move was announced on August 14, 2025, following a series of financial challenges, including a Q2 loss and revenue estimates that were lagged [3]. The stock has been trading lower due to these developments.

Other notable movements include BioXcel Therapeutics Inc., which has seen a 20% increase, and Tonix Pharmaceuticals Holding Corp., which has gained 13%. These companies have been performing well in the market, with Tonix Pharmaceuticals Holding Corp. reaching a significant milestone with its stock price.

In conclusion, the premarket trading on July 2, 2025, has shown significant movements in the healthcare and biotechnology sectors. Propanc Biopharma Inc. and TPI Composites Inc. are leading the charge with their respective announcements and financial performances.

References:
[1] https://finviz.com/quote.ashx?t=PPCB
[2] https://www.quiverquant.com/news/Propanc+Biopharma%2C+Inc.+Announces+Public+Offering+of+Common+Stock+and+Nasdaq+Uplisting
[3] https://finviz.com/quote.ashx?t=TPIC